Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL

NCT: NCT06446817 · RECRUITING

NCT IDNCT06446817
StatusRECRUITING
Start Date2024-12-19
Completion2028-12

Brief Summary

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.

Frequently Asked Questions

What is Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL?

Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL is a clinical trial registered under NCT06446817. Current status: RECRUITING.

What is the status of NCT06446817?

The current status of NCT06446817 (Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL) is: RECRUITING.

When did Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL start?

Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL started on 2024-12-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑